{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:36:34Z","timestamp":1789504594679,"version":"build-2803163510"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:00:00Z","timestamp":1615939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:00:00Z","timestamp":1615939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s10067-021-05691-x","type":"journal-article","created":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T19:02:25Z","timestamp":1616007745000},"page":"2611-2619","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":104,"title":["COVID-19 and the clinical course of rheumatic manifestations"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4631-311X","authenticated-orcid":false,"given":"Sakir","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4188-8486","authenticated-orcid":false,"given":"Olena","family":"Zimba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8749-6018","authenticated-orcid":false,"given":"Armen Yuri","family":"Gasparyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,17]]},"reference":[{"key":"5691_CR1","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/pathogens10020184","volume":"10","author":"A Flores-Alanis","year":"2021","unstructured":"Flores-Alanis A, Cruz-Rangel A, Rodr\u00edguez-G\u00f3mez F, Gonz\u00e1lez J, Torres-Guerrero CA, Delgado G, Cravioto A, Morales-Espinosa R (2021) Molecular epidemiology surveillance of SARS-CoV-2: mutations and genetic diversity one year after emerging. Pathogens 10:184. https:\/\/doi.org\/10.3390\/pathogens10020184","journal-title":"Pathogens"},{"key":"5691_CR2","unstructured":"WHO Coronavirus Disease (COVID-19) Dashboard. https:\/\/covid19.who.int. Accessed 13 Feb 2021"},{"key":"5691_CR3","doi-asserted-by":"publisher","first-page":"e2011834","DOI":"10.1001\/jamanetworkopen.2020.11834","volume":"3","author":"MM Sajadi","year":"2020","unstructured":"Sajadi MM, Habibzadeh P, Vintzileos A, Shokouhi S, Miralles-Wilhelm F, Amoroso A (2020) Temperature, humidity, and latitude analysis to estimate potential spread and seasonality of coronavirus disease 2019 (COVID-19). JAMA Netw Open 3:e2011834. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.11834","journal-title":"JAMA Netw Open"},{"key":"5691_CR4","doi-asserted-by":"publisher","first-page":"5634","DOI":"10.3390\/ijerph17165634","volume":"17","author":"AJ Smit","year":"2020","unstructured":"Smit AJ, Fitchett JM, Engelbrecht FA, Scholes RJ, Dzhivhuho G, Sweijd NA (2020) Winter is coming: a southern hemisphere perspective of the environmental drivers of SARS-CoV-2 and the potential seasonality of COVID-19. Int J Environ Res Public Health 17:5634. https:\/\/doi.org\/10.3390\/ijerph17165634","journal-title":"Int J Environ Res Public Health"},{"key":"5691_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jaut.2019.03.002","volume":"100","author":"E Yamamoto","year":"2019","unstructured":"Yamamoto E, J\u00f8rgensen TN (2019) Immunological effects of vitamin D and their relations to autoimmunity. J Autoimmun 100:7\u201316. https:\/\/doi.org\/10.1016\/j.jaut.2019.03.002","journal-title":"J Autoimmun"},{"key":"5691_CR6","doi-asserted-by":"publisher","unstructured":"Pereira M, Dantas Damascena A, Galv\u00e3o Azevedo LM, de Almeida Oliveira T, da Mota Santana J (2020) Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis. Crit Rev Food Sci Nutr:1\u20139. https:\/\/doi.org\/10.1080\/10408398.2020.1841090","DOI":"10.1080\/10408398.2020.1841090"},{"key":"5691_CR7","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.ajic.2020.06.193","volume":"48","author":"PB Whittemore","year":"2020","unstructured":"Whittemore PB (2020) COVID-19 fatalities, latitude, sunlight, and vitamin D. Am J Infect Control 48:1042\u20131044. https:\/\/doi.org\/10.1016\/j.ajic.2020.06.193","journal-title":"Am J Infect Control"},{"key":"5691_CR8","doi-asserted-by":"publisher","first-page":"102592","DOI":"10.1016\/j.jaut.2020.102592","volume":"117","author":"L Novelli","year":"2021","unstructured":"Novelli L, Motta F, De Santis M et al (2021) The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature. J Autoimmun 117:102592. https:\/\/doi.org\/10.1016\/j.jaut.2020.102592","journal-title":"J Autoimmun"},{"key":"5691_CR9","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.cmi.2020.07.028","volume":"26","author":"B Davido","year":"2020","unstructured":"Davido B, Seang S, Tubiana R, de Truchis P (2020) Post-COVID-19 chronic symptoms: a postinfectious entity? Clin Microbiol Infect 26:1448\u20131449. https:\/\/doi.org\/10.1016\/j.cmi.2020.07.028","journal-title":"Clin Microbiol Infect"},{"key":"5691_CR10","doi-asserted-by":"publisher","first-page":"102597","DOI":"10.1016\/j.autrev.2020.102597","volume":"19","author":"M Ehrenfeld","year":"2020","unstructured":"Ehrenfeld M, Tincani A, Andreoli L, Cattalini M, Greenbaum A, Kanduc D, Alijotas-Reig J, Zinserling V, Semenova N, Amital H, Shoenfeld Y (2020) Covid-19 and autoimmunity. Autoimmun Rev 19:102597. https:\/\/doi.org\/10.1016\/j.autrev.2020.102597","journal-title":"Autoimmun Rev"},{"key":"5691_CR11","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1007\/s10067-020-05190-5","volume":"39","author":"M Soy","year":"2020","unstructured":"Soy M, Keser G, Atag\u00fcnd\u00fcz P, Tabak F, Atag\u00fcnd\u00fcz I, Kayhan S (2020) Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. Clin Rheumatol 39:2085\u20132094. https:\/\/doi.org\/10.1007\/s10067-020-05190-5","journal-title":"Clin Rheumatol"},{"key":"5691_CR12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","volume":"20","author":"M Merad","year":"2020","unstructured":"Merad M, Martin JC (2020) Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol 20:355\u2013362. https:\/\/doi.org\/10.1038\/s41577-020-0331-4","journal-title":"Nat Rev Immunol"},{"key":"5691_CR13","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.abc6027","volume":"369","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, P\u00e9r\u00e9 H, Charbit B, Bondet V, Chenevier-Gobeaux C, Breillat P, Carlier N, Gauzit R, Morbieu C, P\u00e8ne F, Marin N, Roche N, Szwebel TA, Merkling SH, Treluyer JM, Veyer D, Mouthon L, Blanc C, Tharaux PL, Rozenberg F, Fischer A, Duffy D, Rieux-Laucat F, Kern\u00e9is S, Terrier B (2020) Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369:718\u2013724. https:\/\/doi.org\/10.1126\/science.abc6027","journal-title":"Science"},{"key":"5691_CR14","doi-asserted-by":"publisher","first-page":"e20200652","DOI":"10.1084\/jem.20200652","volume":"217","author":"BJ Barnes","year":"2020","unstructured":"Barnes BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, Cools-Lartigue J, Crawford JM, Da\u00dfler-Plenker J, Guerci P, Huynh C, Knight JS, Loda M, Looney MR, McAllister F, Rayes R, Renaud S, Rousseau S, Salvatore S, Schwartz RE, Spicer JD, Yost CC, Weber A, Zuo Y, Egeblad M (2020) Targeting potential drivers of COVID-19: Neutrophil extracellular traps. J Exp Med 217:e20200652. https:\/\/doi.org\/10.1084\/jem.20200652","journal-title":"J Exp Med"},{"key":"5691_CR15","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nrneph.2016.71","volume":"12","author":"S Gupta","year":"2016","unstructured":"Gupta S, Kaplan MJ (2016) The role of neutrophils and NETosis in autoimmune and renal diseases. Nat Rev Nephrol 12:402\u2013413. https:\/\/doi.org\/10.1038\/nrneph.2016.71","journal-title":"Nat Rev Nephrol"},{"key":"5691_CR16","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1111\/cts.12805","volume":"13","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Han T, Chen J, Hou C, Hua L, He S, Guo Y, Zhang S, Wang Y, Yuan J, Zhao C, Zhang J, Jia Q, Zuo X, Li J, Wang L, Cao Q, Jia E (2020) Clinical and autoimmune characteristics of severe and critical cases of COVID-19. Clin Transl Sci 13:1077\u20131086. https:\/\/doi.org\/10.1111\/cts.12805","journal-title":"Clin Transl Sci"},{"key":"5691_CR17","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/art.41425","volume":"72","author":"M Xiao","year":"2020","unstructured":"Xiao M, Zhang Y, Zhang S, Qin X, Xia P, Cao W, Jiang W, Chen H, Ding X, Zhao H, Zhang H, Wang C, Zhao J, Sun X, Tian R, Wu W, Wu D, Ma J, Chen Y, Zhang D, Xie J, Yan X, Zhou X, Liu Z, Wang J, du B, Qin Y, Gao P, Lu M, Hou X, Wu X, Zhu H, Xu Y, Zhang W, Li T, Zhang F, Zhao Y, Li Y, Zhang S (2020) Antiphospholipid antibodies in critically ill patients with COVID-19. Arthritis Rheumatol 72:1998\u20132004. https:\/\/doi.org\/10.1002\/art.41425","journal-title":"Arthritis Rheumatol"},{"key":"5691_CR18","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1111\/bjh.16850","volume":"190","author":"G Bomhof","year":"2020","unstructured":"Bomhof G, Mutsaers PGNJ, Leebeek FWG, Boekhorst PAW, Hofland J, Croles FN, Jansen AJG (2020) COVID-19-associated immune thrombocytopenia. Br J Haematol 190:e61\u2013e64. https:\/\/doi.org\/10.1111\/bjh.16850","journal-title":"Br J Haematol"},{"key":"5691_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/bjh.16794","volume":"190","author":"G Lazarian","year":"2020","unstructured":"Lazarian G, Quinquenel A, Bellal M, Siavellis J, Jacquy C, Re D, Merabet F, Mekinian A, Braun T, Damaj G, Delmer A, Cymbalista F (2020) Autoimmune haemolytic anaemia associated with COVID-19 infection. Br J Haematol 190:29\u201331. https:\/\/doi.org\/10.1111\/bjh.16794","journal-title":"Br J Haematol"},{"key":"5691_CR20","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409\u20131417. https:\/\/doi.org\/10.1007\/s00296-011-1999-3","journal-title":"Rheumatol Int"},{"key":"5691_CR21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S et al (2020) SARS-CoV-2 Cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:271\u2013280.e8. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052","journal-title":"Cell"},{"key":"5691_CR22","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 203:631\u2013637. https:\/\/doi.org\/10.1002\/path.1570","journal-title":"J Pathol"},{"key":"5691_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jinf.2020.04.011","volume":"81","author":"H Tu","year":"2020","unstructured":"Tu H, Tu S, Gao S, Shao A, Sheng J (2020) Current epidemiological and clinical features of COVID-19; a global perspective from China. J Infect 81:1\u20139. https:\/\/doi.org\/10.1016\/j.jinf.2020.04.011","journal-title":"J Infect"},{"key":"5691_CR24","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1007\/s10067-020-05275-1","volume":"39","author":"S Ahmed","year":"2020","unstructured":"Ahmed S, Zimba O, Gasparyan AY (2020) Thrombosis in coronavirus disease 2019 (COVID-19) through the prism of Virchow\u2019s triad. Clin Rheumatol 39:2529\u20132543. https:\/\/doi.org\/10.1007\/s10067-020-05275-1","journal-title":"Clin Rheumatol"},{"key":"5691_CR25","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/s41588-020-00732-8","volume":"52","author":"KW Ng","year":"2020","unstructured":"Ng KW, Attig J, Bolland W, Young GR, Major J, Wrobel AG, Gamblin S, Wack A, Kassiotis G (2020) Tissue-specific and interferon-inducible expression of nonfunctional ACE2 through endogenous retroelement co-option. Nat Genet 52:1294\u20131302. https:\/\/doi.org\/10.1038\/s41588-020-00732-8","journal-title":"Nat Genet"},{"key":"5691_CR26","doi-asserted-by":"publisher","first-page":"607069","DOI":"10.3389\/fimmu.2020.607069","volume":"11","author":"J-M Berthelot","year":"2020","unstructured":"Berthelot J-M, Liot\u00e9 F, Maugars Y, Sibilia J (2020) Lymphocyte changes in severe COVID-19: delayed over-activation of STING? Front Immunol 11:607069. https:\/\/doi.org\/10.3389\/fimmu.2020.607069","journal-title":"Front Immunol"},{"key":"5691_CR27","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","volume":"383","author":"M Ackermann","year":"2020","unstructured":"Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, Li WW, Li VW, Mentzer SJ, Jonigk D (2020) Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 383:120\u2013128. https:\/\/doi.org\/10.1056\/NEJMoa2015432","journal-title":"N Engl J Med"},{"key":"5691_CR28","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","volume":"181","author":"V Monteil","year":"2020","unstructured":"Monteil V, Kwon H, Prado P et al (2020) Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell 181:905\u2013913.e7. https:\/\/doi.org\/10.1016\/j.cell.2020.04.004","journal-title":"Cell"},{"key":"5691_CR29","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet 395:1417\u20131418. https:\/\/doi.org\/10.1016\/S0140-6736(20)30937-5","journal-title":"Lancet"},{"key":"5691_CR30","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00296-020-04768-1","volume":"41","author":"E Bilgin","year":"2021","unstructured":"Bilgin E, Ertenli AI (2021) Proposal of a new nomenclature for the underlying pathogenetic mechanism of severe coronavirus disease-19: \u201cinflammatory thrombosis with immune endotheliitis\u2014ITIE\u201d. Rheumatol Int 41:679\u2013680. https:\/\/doi.org\/10.1007\/s00296-020-04768-1","journal-title":"Rheumatol Int"},{"key":"5691_CR31","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1161\/CIRCULATIONAHA.120.052824","volume":"143","author":"IR McCracken","year":"2021","unstructured":"McCracken IR, Gaye S, He L et al (2021) Lack of evidence of angiotensin-converting enzyme 2 expression and replicative infection by SARS-CoV-2 in human endothelial cells. Circulation 143:865\u2013868. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.052824","journal-title":"Circulation"},{"key":"5691_CR32","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3390\/v11080762","volume":"11","author":"MK Smatti","year":"2019","unstructured":"Smatti MK, Cyprian FS, Nasrallah GK, al Thani AA, Almishal RO, Yassine HM (2019) Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms. Viruses 11:762. https:\/\/doi.org\/10.3390\/v11080762","journal-title":"Viruses"},{"key":"5691_CR33","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/BOR.0000000000000396","volume":"29","author":"A Tanay","year":"2017","unstructured":"Tanay A (2017) Chikungunya virus and autoimmunity. Curr Opin Rheumatol 29:389\u2013393. https:\/\/doi.org\/10.1097\/BOR.0000000000000396","journal-title":"Curr Opin Rheumatol"},{"key":"5691_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jaut.2017.06.001","volume":"82","author":"A Watad","year":"2017","unstructured":"Watad A, Azrielant S, Bragazzi NL, Sharif K, David P, Katz I, Aljadeff G, Quaresma M, Tanay G, Adawi M, Amital H, Shoenfeld Y (2017) Seasonality and autoimmune diseases: the contribution of the four seasons to the mosaic of autoimmunity. J Autoimmun 82:13\u201330. https:\/\/doi.org\/10.1016\/j.jaut.2017.06.001","journal-title":"J Autoimmun"},{"key":"5691_CR35","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1002\/jmv.26007","volume":"92","author":"V Kipkorir","year":"2020","unstructured":"Kipkorir V, Cheruiyot I, Ngure B, Misiani M, Munguti J (2020) Prolonged SARS-CoV-2 RNA detection in anal\/rectal swabs and stool specimens in COVID-19 patients after negative conversion in nasopharyngeal RT-PCR test. J Med Virol 92:2328\u20132331. https:\/\/doi.org\/10.1002\/jmv.26007","journal-title":"J Med Virol"},{"key":"5691_CR36","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s12250-020-00312-4","volume":"35","author":"J Cai","year":"2020","unstructured":"Cai J, Wang X, Zhao J, Ge Y, Xu J, Tian H, Chang H, Xia A, Wang J, Zhang J, Wei Z, Li J, Wang C, Wang J, Zhu Q, Zhai X, Zeng M (2020) Comparison of clinical and epidemiological characteristics of asymptomatic and symptomatic SARS-CoV-2 infection in children. Virol Sin 35:803\u2013810. https:\/\/doi.org\/10.1007\/s12250-020-00312-4","journal-title":"Virol Sin"},{"key":"5691_CR37","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1002\/jmv.26114","volume":"92","author":"H Kang","year":"2020","unstructured":"Kang H, Wang Y, Tong Z, Liu X (2020) Retest positive for SARS-CoV-2 RNA of \u201crecovered\u201d patients with COVID-19: persistence, sampling issues, or re-infection? J Med Virol 92:2263\u20132265. https:\/\/doi.org\/10.1002\/jmv.26114","journal-title":"J Med Virol"},{"key":"5691_CR38","doi-asserted-by":"publisher","first-page":"102421","DOI":"10.1016\/j.jaut.2020.102421","volume":"109","author":"J Krainer","year":"2020","unstructured":"Krainer J, Siebenhandl S, Weinh\u00e4usel A (2020) Systemic autoinflammatory diseases. J Autoimmun 109:102421. https:\/\/doi.org\/10.1016\/j.jaut.2020.102421","journal-title":"J Autoimmun"},{"key":"5691_CR39","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s12026-020-09137-5","volume":"68","author":"D Birra","year":"2020","unstructured":"Birra D, Benucci M, Landolfi L, Merchionda A, Loi G, Amato P, Licata G, Quartuccio L, Triggiani M, Moscato P (2020) COVID 19: a clue from innate immunity. Immunol Res 68:161\u2013168. https:\/\/doi.org\/10.1007\/s12026-020-09137-5","journal-title":"Immunol Res"},{"key":"5691_CR40","doi-asserted-by":"publisher","first-page":"6151","DOI":"10.1172\/JCI141374","volume":"130","author":"P Skendros","year":"2020","unstructured":"Skendros P, Mitsios A, Chrysanthopoulou A, Mastellos DC, Metallidis S, Rafailidis P, Ntinopoulou M, Sertaridou E, Tsironidou V, Tsigalou C, Tektonidou M, Konstantinidis T, Papagoras C, Mitroulis I, Germanidis G, Lambris JD, Ritis K (2020) Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. J Clin Invest 130:6151\u20136157. https:\/\/doi.org\/10.1172\/JCI141374","journal-title":"J Clin Invest"},{"key":"5691_CR41","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41584-020-0448-7","volume":"16","author":"C Galeotti","year":"2020","unstructured":"Galeotti C, Bayry J (2020) Autoimmune and inflammatory diseases following COVID-19. Nat Rev Rheumatol 16:413\u2013414. https:\/\/doi.org\/10.1038\/s41584-020-0448-7","journal-title":"Nat Rev Rheumatol"},{"key":"5691_CR42","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1111\/bjd.18203","volume":"181","author":"E Sbidian","year":"2019","unstructured":"Sbidian E, Madrange M, Viguier M, Salmona M, Duchatelet S, Hovnanian A, Smahi A, le Goff J, Bachelez H (2019) Respiratory virus infection triggers acute psoriasis flares across different clinical subtypes and genetic backgrounds. Br J Dermatol 181:1304\u20131306. https:\/\/doi.org\/10.1111\/bjd.18203","journal-title":"Br J Dermatol"},{"key":"5691_CR43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.imlet.2020.09.005","volume":"228","author":"SA Sawadogo","year":"2020","unstructured":"Sawadogo SA, Dighero-Kemp B, Ou\u00e9draogo D-D, Hensley L, Sakand\u00e9 J (2020) How NETosis could drive \u201cpost-COVID-19 syndrome\u201d among survivors. Immunol Lett 228:35\u201337. https:\/\/doi.org\/10.1016\/j.imlet.2020.09.005","journal-title":"Immunol Lett"},{"key":"5691_CR44","doi-asserted-by":"publisher","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","volume":"370","author":"P Bastard","year":"2020","unstructured":"Bastard P, Rosen LB, Zhang Q et al (2020) Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 370:eabd4585. https:\/\/doi.org\/10.1126\/science.abd4585","journal-title":"Science"},{"key":"5691_CR45","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1007\/s10067-020-05145-w","volume":"39","author":"S Ahmed","year":"2020","unstructured":"Ahmed S, Anirvan P (2020) Reply to Rheumatologists\u2019 perspective on coronavirus disease 19: is heparin the dark horse for COVID-19? Clin Rheumatol 39:2099\u20132100. https:\/\/doi.org\/10.1007\/s10067-020-05145-w","journal-title":"Clin Rheumatol"},{"key":"5691_CR46","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1056\/NEJMc2007575","volume":"382","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, Chen H, Ding X, Zhao H, Zhang H, Wang C, Zhao J, Sun X, Tian R, Wu W, Wu D, Ma J, Chen Y, Zhang D, Xie J, Yan X, Zhou X, Liu Z, Wang J, du B, Qin Y, Gao P, Qin X, Xu Y, Zhang W, Li T, Zhang F, Zhao Y, Li Y, Zhang S (2020) Coagulopathy and antiphospholipid antibodies in patients with COVID-19. N Engl J Med 382:e38. https:\/\/doi.org\/10.1056\/NEJMc2007575","journal-title":"N Engl J Med"},{"key":"5691_CR47","doi-asserted-by":"publisher","unstructured":"Amezcua-Guerra LM, Rojas-Velasco G, Brianza-Padilla M, V\u00e1zquez-Rangel A, M\u00e1rquez-Velasco R, Baranda-Tovar F, Springall R, Gonzalez-Pacheco H, Ju\u00e1rez-Vicu\u00f1a Y, Tavera-Alonso C, Sanchez-Mu\u00f1oz F, Hern\u00e1ndez-Salas M (2020) Presence of antiphospholipid antibodies in COVID-19: case series study. Ann Rheum Dis:annrheumdis-2020-218100. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218100","DOI":"10.1136\/annrheumdis-2020-218100"},{"key":"5691_CR48","doi-asserted-by":"publisher","first-page":"eabd3876","DOI":"10.1126\/scitranslmed.abd3876","volume":"12","author":"Y Zuo","year":"2020","unstructured":"Zuo Y, Estes SK, Ali RA et al (2020) Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci Transl Med 12:eabd3876. https:\/\/doi.org\/10.1126\/scitranslmed.abd3876","journal-title":"Sci Transl Med"},{"key":"5691_CR49","doi-asserted-by":"publisher","first-page":"584241","DOI":"10.3389\/fimmu.2020.584241","volume":"11","author":"MO Borghi","year":"2020","unstructured":"Borghi MO, Beltagy A, Garrafa E, Curreli D, Cecchini G, Bodio C, Grossi C, Blengino S, Tincani A, Franceschini F, Andreoli L, Lazzaroni MG, Piantoni S, Masneri S, Crisafulli F, Brugnoni D, Muiesan ML, Salvetti M, Parati G, Torresani E, Mahler M, Heilbron F, Pregnolato F, Pengo M, Tedesco F, Pozzi N, Meroni PL (2020) Anti-phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndrome. Front Immunol 11:584241. https:\/\/doi.org\/10.3389\/fimmu.2020.584241","journal-title":"Front Immunol"},{"key":"5691_CR50","doi-asserted-by":"publisher","unstructured":"Zuniga M, Gomes C, Carsons SE, et al (2021) Autoimmunity to the lung protective phospholipid-binding protein annexin A2 predicts mortality among hospitalized COVID-19 patients. medRxiv 2020.12.28.20248807. https:\/\/doi.org\/10.1101\/2020.12.28.20248807","DOI":"10.1101\/2020.12.28.20248807"},{"key":"5691_CR51","doi-asserted-by":"publisher","first-page":"100073","DOI":"10.1016\/j.jtauto.2020.100073","volume":"3","author":"LA Lerma","year":"2020","unstructured":"Lerma LA, Chaudhary A, Bryan A, Morishima C, Wener MH, Fink SL (2020) Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID-19). J Transl Autoimmun 3:100073. https:\/\/doi.org\/10.1016\/j.jtauto.2020.100073","journal-title":"J Transl Autoimmun"},{"key":"5691_CR52","doi-asserted-by":"publisher","unstructured":"Wang JY, Zhang W, Roehrl MW et al (2021) An autoantigen atlas from human lung HFL1 cells offers clues to neurological and diverse autoimmune manifestations of COVID-19. bioRxiv. https:\/\/doi.org\/10.1101\/2021.01.24.427965","DOI":"10.1101\/2021.01.24.427965"},{"key":"5691_CR53","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1056\/NEJMc2010472","volume":"382","author":"A-A Zulfiqar","year":"2020","unstructured":"Zulfiqar A-A, Lorenzo-Villalba N, Hassler P, Andr\u00e8s E (2020) Immune thrombocytopenic purpura in a patient with Covid-19. N Engl J Med 382:e43. https:\/\/doi.org\/10.1056\/NEJMc2010472","journal-title":"N Engl J Med"},{"key":"5691_CR54","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1056\/NEJMc2009191","volume":"382","author":"G Toscano","year":"2020","unstructured":"Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, Franciotta D, Baldanti F, Daturi R, Postorino P, Cavallini A, Micieli G (2020) Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2. N Engl J Med 382:2574\u20132576. https:\/\/doi.org\/10.1056\/NEJMc2009191","journal-title":"N Engl J Med"},{"key":"5691_CR55","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/jns.12382","volume":"25","author":"E Scheidl","year":"2020","unstructured":"Scheidl E, Canseco DD, Hadji-Naumov A, Bereznai B (2020) Guillain-Barr\u00e9 syndrome during SARS-CoV-2 pandemic: a case report and review of recent literature. J Peripher Nerv Syst 25:204\u2013207. https:\/\/doi.org\/10.1111\/jns.12382","journal-title":"J Peripher Nerv Syst"},{"key":"5691_CR56","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1212\/WNL.0000000000009700","volume":"95","author":"M Dinkin","year":"2020","unstructured":"Dinkin M, Gao V, Kahan J, Bobker S, Simonetto M, Wechsler P, Harpe J, Greer C, Mints G, Salama G, Tsiouris AJ, Leifer D (2020) COVID-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology 95:221\u2013223. https:\/\/doi.org\/10.1212\/WNL.0000000000009700","journal-title":"Neurology"},{"key":"5691_CR57","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1507\/endocrj.EJ20-0443","volume":"68","author":"G Speer","year":"2021","unstructured":"Speer G, Somogyi P (2021) Thyroid complications of SARS and coronavirus disease 2019 (COVID-19). Endocr J 68:129\u2013136. https:\/\/doi.org\/10.1507\/endocrj.EJ20-0443","journal-title":"Endocr J"},{"key":"5691_CR58","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/jmv.26296","volume":"93","author":"EM Saricaoglu","year":"2020","unstructured":"Saricaoglu EM, Hasanoglu I, Guner R (2020) The first reactive arthritis case associated with COVID-19. J Med Virol 93:192\u2013193. https:\/\/doi.org\/10.1002\/jmv.26296","journal-title":"J Med Virol"},{"key":"5691_CR59","doi-asserted-by":"publisher","first-page":"e001350","DOI":"10.1136\/rmdopen-2020-001350","volume":"6","author":"K Ono","year":"2020","unstructured":"Ono K, Kishimoto M, Shimasaki T, Uchida H, Kurai D, Deshpande GA, Komagata Y, Kaname S (2020) Reactive arthritis after COVID-19 infection. RMD Open 6:e001350. https:\/\/doi.org\/10.1136\/rmdopen-2020-001350","journal-title":"RMD Open"},{"key":"5691_CR60","doi-asserted-by":"publisher","first-page":"e11761","DOI":"10.7759\/cureus.11761","volume":"12","author":"I Jali","year":"2020","unstructured":"Jali I (2020) Reactive arthritis after COVID-19 infection. Cureus 12:e11761. https:\/\/doi.org\/10.7759\/cureus.11761","journal-title":"Cureus"},{"key":"5691_CR61","doi-asserted-by":"publisher","unstructured":"Coath FL, Mackay J, Gaffney JK (2021) Axial presentation of reactive arthritis secondary to Covid-19 infection. Rheumatology (Oxford):keab009. https:\/\/doi.org\/10.1093\/rheumatology\/keab009","DOI":"10.1093\/rheumatology\/keab009"},{"key":"5691_CR62","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/rheumatology\/keaa689","volume":"60","author":"HM Schenker","year":"2021","unstructured":"Schenker HM, Hagen M, Simon D, Schett G, Manger B (2021) Reactive arthritis and cutaneous vasculitis after SARS-CoV-2 infection. Rheumatology (Oxford) 60:479\u2013480. https:\/\/doi.org\/10.1093\/rheumatology\/keaa689","journal-title":"Rheumatology (Oxford)"},{"key":"5691_CR63","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/RHU.0000000000001560","volume":"26","author":"IY Liew","year":"2020","unstructured":"Liew IY, Mak TM, Cui L, Vasoo S, Lim XR (2020) A case of reactive arthritis secondary to coronavirus disease 2019 infection. J Clin Rheumatol 26:233. https:\/\/doi.org\/10.1097\/RHU.0000000000001560","journal-title":"J Clin Rheumatol"},{"key":"5691_CR64","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1111\/jdv.16589","volume":"34","author":"L Castelnovo","year":"2020","unstructured":"Castelnovo L, Capelli F, Tamburello A, Faggioli PM, Mazzone A (2020) Symmetric cutaneous vasculitis in COVID-19 pneumonia. J Eur Acad Dermatol Venereol 34:e362\u2013e363. https:\/\/doi.org\/10.1111\/jdv.16589","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5691_CR65","doi-asserted-by":"publisher","first-page":"e579","DOI":"10.1111\/jdv.16737","volume":"34","author":"V Caputo","year":"2020","unstructured":"Caputo V, Schroeder J, Rongioletti F (2020) A generalized purpuric eruption with histopathologic features of leucocytoclastic vasculitis in a patient severely ill with COVID-19. J Eur Acad Dermatol Venereol 34:e579\u2013e581. https:\/\/doi.org\/10.1111\/jdv.16737","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5691_CR66","doi-asserted-by":"publisher","first-page":"e566","DOI":"10.1111\/jdv.16713","volume":"34","author":"D de Perosanz-Lobo","year":"2020","unstructured":"de Perosanz-Lobo D, Fernandez-Nieto D, Burgos-Blasco P, Selda-Enriquez G, Carretero I, Moreno C, Fern\u00e1ndez-Guarino M (2020) Urticarial vasculitis in COVID-19 infection: a vasculopathy-related symptom? J Eur Acad Dermatol Venereol 34:e566\u2013e568. https:\/\/doi.org\/10.1111\/jdv.16713","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5691_CR67","doi-asserted-by":"publisher","unstructured":"Najar Nobari N, Seirafianpour F, Mashayekhi F, Goodarzi A (2020) A systematic review on treatment-related mucocutaneous reactions in COVID-19 patients. Dermatol Ther:e14662. https:\/\/doi.org\/10.1111\/dth.14662","DOI":"10.1111\/dth.14662"},{"key":"5691_CR68","doi-asserted-by":"publisher","unstructured":"Perna A, Passiatore M, Massaro A, Terrinoni A, Bianchi L, Cilli V, D\u2019Orio M, Proietti L, Taccardo G, de Vitis R (2021) Skin manifestations in COVID-19 patients, state of the art. A systematic review. Int J Dermatol. https:\/\/doi.org\/10.1111\/ijd.15414","DOI":"10.1111\/ijd.15414"},{"key":"5691_CR69","doi-asserted-by":"publisher","first-page":"9695","DOI":"10.26355\/eurrev_202009_23060","volume":"24","author":"R Bonometti","year":"2020","unstructured":"Bonometti R, Sacchi MC, Stobbione P et al (2020) The first case of systemic lupus erythematosus (SLE) triggered by COVID-19 infection. Eur Rev Med Pharmacol Sci 24:9695\u20139697. https:\/\/doi.org\/10.26355\/eurrev_202009_23060","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"5691_CR70","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1007\/s10067-020-05310-1","volume":"39","author":"E Mantovani Cardoso","year":"2020","unstructured":"Mantovani Cardoso E, Hundal J, Feterman D, Magaldi J (2020) Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology. Clin Rheumatol 39:2811\u20132815. https:\/\/doi.org\/10.1007\/s10067-020-05310-1","journal-title":"Clin Rheumatol"},{"key":"5691_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00296-021-04794-7","volume":"4","author":"AE Gracia-Ramos","year":"2021","unstructured":"Gracia-Ramos AE, Saavedra-Salinas M\u00c1 (2021) Can the SARS-CoV-2 infection trigger systemic lupus erythematosus? A case-based review. Rheumatol Int 4:1\u201311. https:\/\/doi.org\/10.1007\/s00296-021-04794-7","journal-title":"Rheumatol Int"},{"key":"5691_CR72","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1136\/annrheumdis-2020-217573","volume":"80","author":"M Beydon","year":"2020","unstructured":"Beydon M, Chevalier K, Tabaa OA et al (2020) Myositis as a manifestation of SARS-CoV-2. Ann Rheum Dis 80:e42. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217573","journal-title":"Ann Rheum Dis"},{"key":"5691_CR73","doi-asserted-by":"publisher","unstructured":"Abdullahi A, Candan SA, Abba MA, Bello AH, Alshehri MA, Afamefuna Victor E, Umar NA, Kundakci B (2020) Neurological and musculoskeletal features of COVID-19: a systematic review and meta-analysis. Front Neurol 11. https:\/\/doi.org\/10.3389\/fneur.2020.00687","DOI":"10.3389\/fneur.2020.00687"},{"key":"5691_CR74","doi-asserted-by":"publisher","first-page":"m2094","DOI":"10.1136\/bmj.m2094","volume":"369","author":"J Toubiana","year":"2020","unstructured":"Toubiana J, Poirault C, Corsia A, Bajolle F, Fourgeaud J, Angoulvant F, Debray A, Basmaci R, Salvador E, Biscardi S, Frange P, Chalumeau M, Casanova JL, Cohen JF, Allali S (2020) Kawasaki-like multisystem inflammatory syndrome in children during the COVID-19 pandemic in Paris, France: prospective observational study. BMJ 369:m2094. https:\/\/doi.org\/10.1136\/bmj.m2094","journal-title":"BMJ"},{"key":"5691_CR75","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1136\/annrheumdis-2020-217960","volume":"79","author":"M Pouletty","year":"2020","unstructured":"Pouletty M, Borocco C, Ouldali N, Caseris M, Basmaci R, Lachaume N, Bensaid P, Pichard S, Kouider H, Morelle G, Craiu I, Pondarre C, Deho A, Maroni A, Oualha M, Amoura Z, Haroche J, Chommeloux J, Bajolle F, Beyler C, Bonacorsi S, Carcelain G, Kon\u00e9-Paut I, Bader-Meunier B, Faye A, Meinzer U, Galeotti C, Melki I (2020) Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort. Ann Rheum Dis 79:999\u20131006. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217960","journal-title":"Ann Rheum Dis"},{"key":"5691_CR76","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1111\/epi.16683","volume":"61","author":"E Carroll","year":"2020","unstructured":"Carroll E, Neumann H, Aguero-Rosenfeld ME, Lighter J, Czeisler BM, Melmed K, Lewis A (2020) Post-COVID-19 inflammatory syndrome manifesting as refractory status epilepticus. Epilepsia 61:e135\u2013e139. https:\/\/doi.org\/10.1111\/epi.16683","journal-title":"Epilepsia"},{"key":"5691_CR77","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2020-217871","volume":"79","author":"M Gianfrancesco","year":"2020","unstructured":"Gianfrancesco M, Hyrich KL, Al-Adely S et al (2020) Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis 79:859\u2013866. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217871","journal-title":"Ann Rheum Dis"},{"key":"5691_CR78","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","volume":"584","author":"EJ Williamson","year":"2020","unstructured":"Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, Curtis HJ, Mehrkar A, Evans D, Inglesby P, Cockburn J, McDonald HI, MacKenna B, Tomlinson L, Douglas IJ, Rentsch CT, Mathur R, Wong AYS, Grieve R, Harrison D, Forbes H, Schultze A, Croker R, Parry J, Hester F, Harper S, Perera R, Evans SJW, Smeeth L, Goldacre B (2020) Factors associated with COVID-19-related death using OpenSAFELY. Nature 584:430\u2013436. https:\/\/doi.org\/10.1038\/s41586-020-2521-4","journal-title":"Nature"},{"key":"5691_CR79","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1016\/S2665-9913(20)30422-7","volume":"3","author":"A Jorge","year":"2021","unstructured":"Jorge A, D\u2019Silva KM, Cohen A et al (2021) Temporal trends in severe COVID-19 outcomes in patients with rheumatic disease: a cohort study. Lancet Rheumatol 3:e131\u2013e137. https:\/\/doi.org\/10.1016\/S2665-9913(20)30422-7","journal-title":"Lancet Rheumatol"},{"key":"5691_CR80","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00296-020-04764-5","volume":"41","author":"S Ahmed","year":"2021","unstructured":"Ahmed S, Gasparyan AY, Zimba O (2021) Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic. Rheumatol Int 41:243\u2013256. https:\/\/doi.org\/10.1007\/s00296-020-04764-5","journal-title":"Rheumatol Int"},{"key":"5691_CR81","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/RHU.0000000000001531","volume":"26","author":"S Raghavan","year":"2020","unstructured":"Raghavan S, Gonakoti S, Asemota IR, Mba B (2020) A case of systemic lupus erythematosus flare triggered by severe coronavirus disease 2019. J Clin Rheumatol 26:234\u2013235. https:\/\/doi.org\/10.1097\/RHU.0000000000001531","journal-title":"J Clin Rheumatol"},{"key":"5691_CR82","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1007\/s10067-020-05334-7","volume":"39","author":"C Ferri","year":"2020","unstructured":"Ferri C, Giuggioli D, Raimondo V et al (2020) COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series. Clin Rheumatol 39:3195\u20133204. https:\/\/doi.org\/10.1007\/s10067-020-05334-7","journal-title":"Clin Rheumatol"},{"key":"5691_CR83","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.3346\/jkms.2020.35.e176","volume":"35","author":"AY Gasparyan","year":"2020","unstructured":"Gasparyan AY, Misra DP, Yessirkepov M, Zimba O (2020) Perspectives of immune therapy in coronavirus disease 2019. J Korean Med Sci 35:e176. https:\/\/doi.org\/10.3346\/jkms.2020.35.e176","journal-title":"J Korean Med Sci"},{"key":"5691_CR84","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2023184","volume":"384","author":"H Pan","year":"2021","unstructured":"WHO Solidarity Trial Consortium, Pan H, Peto R et al (2021) Repurposed antiviral drugs for Covid-19 - interim WHO solidarity trial results. N Engl J Med 384:497\u2013511. https:\/\/doi.org\/10.1056\/NEJMoa2023184","journal-title":"N Engl J Med"},{"key":"5691_CR85","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1007\/s11606-020-06146-w","volume":"35","author":"A Elavarasi","year":"2020","unstructured":"Elavarasi A, Prasad M, Seth T, Sahoo RK, Madan K, Nischal N, Soneja M, Sharma A, Maulik SK, Shalimar, Garg P (2020) Chloroquine and hydroxychloroquine for the treatment of COVID-19: a systematic review and meta-analysis. J Gen Intern Med 35:3308\u20133314. https:\/\/doi.org\/10.1007\/s11606-020-06146-w","journal-title":"J Gen Intern Med"},{"key":"5691_CR86","doi-asserted-by":"publisher","unstructured":"Tardif J-C, Bouabdallaoui N, L\u2019Allier PL, et al (2021) Efficacy of colchicine in non-hospitalized patients with COVID-19. medRxiv 2021.01.26.21250494. https:\/\/doi.org\/10.1101\/2021.01.26.21250494","DOI":"10.1101\/2021.01.26.21250494"},{"key":"5691_CR87","doi-asserted-by":"publisher","unstructured":"Alunno A, Najm A, Machado PM, Bertheussen H, Burmester GR, Carubbi F, de Marco G, Giacomelli R, Hermine O, Isaacs JD, Kon\u00e9-Paut I, Magro-Checa C, McInnes I, Meroni PL, Quartuccio L, Ramanan AV, Ramos-Casals M, Rodr\u00edguez Carrio J, Schulze-Koops H, Stamm TA, Tas SW, Terrier B, McGonagle DG, Mariette X (2021) EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19. Ann Rheum Dis:annrheumdis-2020-219724. https:\/\/doi.org\/10.1136\/annrheumdis-2020-219724","DOI":"10.1136\/annrheumdis-2020-219724"},{"key":"5691_CR88","doi-asserted-by":"publisher","first-page":"110345","DOI":"10.1016\/j.mehy.2020.110345","volume":"145","author":"CA Ca\u00f1as","year":"2020","unstructured":"Ca\u00f1as CA (2020) The triggering of post-COVID-19 autoimmunity phenomena could be associated with both transient immunosuppression and an inappropriate form of immune reconstitution in susceptible individuals. Med Hypotheses 145:110345. https:\/\/doi.org\/10.1016\/j.mehy.2020.110345","journal-title":"Med Hypotheses"},{"key":"5691_CR89","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s00296-020-04639-9","volume":"40","author":"S Shah","year":"2020","unstructured":"Shah S, Danda D, Kavadichanda C, Das S, Adarsh MB, Negi VS (2020) Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment. Rheumatol Int 40:1539\u20131554. https:\/\/doi.org\/10.1007\/s00296-020-04639-9","journal-title":"Rheumatol Int"},{"key":"5691_CR90","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1038\/emi.2012.2","volume":"1","author":"PJ Lachmann","year":"2012","unstructured":"Lachmann PJ (2012) The use of antibodies in the prophylaxis and treatment of infections. Emerg Microbes Infect 1:e11. https:\/\/doi.org\/10.1038\/emi.2012.2","journal-title":"Emerg Microbes Infect"},{"key":"5691_CR91","doi-asserted-by":"publisher","unstructured":"Kamal M, Abo Omirah M, Hussein A, Saeed H (2020) Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract:e13746. https:\/\/doi.org\/10.1111\/ijcp.13746","DOI":"10.1111\/ijcp.13746"},{"key":"5691_CR92","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1056\/NEJMoa2020283","volume":"383","author":"D Ellinghaus","year":"2020","unstructured":"Severe Covid-19 GWAS Group, Ellinghaus D, Degenhardt F et al (2020) Genomewide association study of severe Covid-19 with respiratory failure. N Engl J Med 383:1522\u20131534. https:\/\/doi.org\/10.1056\/NEJMoa2020283","journal-title":"N Engl J Med"},{"key":"5691_CR93","doi-asserted-by":"publisher","first-page":"628340","DOI":"10.1155\/2015\/628340","volume":"2015","author":"P Bekker","year":"2015","unstructured":"Bekker P, Ebsworth K, Walters MJ, Berahovich RD, Ertl LS, Charvat TT, Punna S, Powers JP, Campbell JJ, Sullivan TJ, Jaen JC, Schall TJ (2015) CCR9 Antagonists in the treatment of ulcerative colitis. Mediat Inflamm 2015:628340\u2013628310. https:\/\/doi.org\/10.1155\/2015\/628340","journal-title":"Mediat Inflamm"},{"key":"5691_CR94","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/rheumatology\/keh147","volume":"43","author":"C-R Wang","year":"2004","unstructured":"Wang C-R, Liu M-F, Huang Y-H, Chen H-C (2004) Up-regulation of XCR1 expression in rheumatoid joints. Rheumatology (Oxford) 43:569\u2013573. https:\/\/doi.org\/10.1093\/rheumatology\/keh147","journal-title":"Rheumatology (Oxford)"},{"key":"5691_CR95","doi-asserted-by":"publisher","unstructured":"Umbrello M, Nespoli S, Pisano E et al Autoantibodies in severe COVID-19-related acute respiratory distress syndrome: just innocent bystanders? Int J Rheum Dis. https:\/\/doi.org\/10.1111\/1756-185X.14077","DOI":"10.1111\/1756-185X.14077"},{"key":"5691_CR96","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11547-020-01295-8","volume":"126","author":"B Shaw","year":"2021","unstructured":"Shaw B, Daskareh M, Gholamrezanezhad A (2021) The lingering manifestations of COVID-19 during and after convalescence: update on long-term pulmonary consequences of coronavirus disease 2019 (COVID-19). Radiol Med 126:40\u201346. https:\/\/doi.org\/10.1007\/s11547-020-01295-8","journal-title":"Radiol Med"},{"key":"5691_CR97","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1016\/j.hrthm.2020.06.026","volume":"17","author":"RD Mitrani","year":"2020","unstructured":"Mitrani RD, Dabas N, Goldberger JJ (2020) COVID-19 cardiac injury: implications for long-term surveillance and outcomes in survivors. Heart Rhythm 17:1984\u20131990. https:\/\/doi.org\/10.1016\/j.hrthm.2020.06.026","journal-title":"Heart Rhythm"},{"key":"5691_CR98","doi-asserted-by":"publisher","first-page":"jrm00063","DOI":"10.2340\/16501977-2694","volume":"52","author":"H Ahmed","year":"2020","unstructured":"Ahmed H, Patel K, Greenwood DC et al (2020) Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: a systematic review and meta-analysis. J Rehabil Med 52:jrm00063. https:\/\/doi.org\/10.2340\/16501977-2694","journal-title":"J Rehabil Med"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05691-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-05691-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05691-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T12:14:03Z","timestamp":1623240843000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-05691-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,17]]},"references-count":98,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["5691"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-05691-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,17]]},"assertion":[{"value":"22 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"All views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of any institution or association.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}